top of page
Eradicus

We were founded to bring about a transformative impact on human health and biosecurity.

We were founded with the goal of mastering the critical know-how of designing and manufacturing molecular chemistries for detecting infectious pathogens.

 

Our business mandate was built around innovating and developing diagnostic solutions that could achieve our founders vision of making infectious diagnostics disruptively accessible in resource limited settings.

Gurugram,India

Global Manufacturing Hub

R&D Centre

Gémenos, France

Since 2019, we have 'mastered the critical know-how of molecular chemistries, design & development processes, and manufacturing quality systems.

Quality Assurance Standard for Manufacturing and Design & Development

ISO 13485: 2016

In-Vitro Diagnostic Molecular Assays Manufactured

> 05 million

Diagnostic Designs Under Development

>135

Maximum Impact.
One Mission At A Time.

We believe that working in a mission mode yields the highest impact of our expertise and capabilities.

Mission 01

Objective: Emergency response to COVID-19 Pandemic by means of making molecular diagnostic solutions highly accessible in developed and developing geographies.

Status
Successfully Completed

Learn More

Mission 02

Objective: Democratise Hepatitis B Virus Molecular Diagnostics in High Incidence Geographies.

Status
Active,
Field Deployment

Learn More

Mission 03

Objective: Deployment of highly affordable next-generation molecular diagnostic solutions for screening and detection of mycobacterium tuberculosis and drug resistance in high incidence geographies.

Status
Active,
Regulatory Review

Learn More
bottom of page